EXOME ASSET MANAGEMENT LLC
Adviser information for EXOME ASSET MANAGEMENT LLC last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 9 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 1 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 5 | $181.8M |
Non-Discretionary | 0 | $0 |
Total | 5 | $181.8M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 5 | $181.8M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 40 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
330 MADISON AVENUESUITE 3010
NEW YORK
NY
United States
Monday - Friday, 9AM - 5PM
Tel: 212-403-3900, Fax: 323-297-6987
Chief Compliance Officer
BRIANNE SHERGILL
HEAD OF INVESTOR SERVICES
330 MADISON AVENUE
SUITE 3010
NEW YORK
NY
United States
Tel:
212-403-3909
Fax:
323-297-6987
S********@*************M
(Full email address available in API data)
Industry Affiliates
EXOME ASSET GP LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
EMERGING MARKETS HEALTHCARE PARTNERS LLC | Hedge Fund | $78.8M | $1.0M | 39 |
WORLDWIDE HEALTHCARE PARTNERS LLC | Hedge Fund | $87.0M | $1.0M | 23 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
ISALY, SAMUEL, DAVID | Individual | – | MANAGING MEMBER | 05/2018 | > 75% |
SHERGILL, BRIANNE | Individual | – | CHIEF COMPLIANCE OFFICER | 10/2022 | < 5% |
FORSCHNER, ALEX, R | Individual | – | PRESIDENT | 09/2023 | 10-25% |
NARVAEZ, JOSEPH, A | Individual | – | CHIEF OPERATING OFFICER | 09/2023 | 10-25% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABCELLERA BIOLOGICS INC | COM | 2M | 515K | – |
ADAGENE INC | ADS | 462K | 151K | – |
ALPHATEC HLDGS INC | COM NEW | 2M | 162K | – |
ALVOTECH | ORDINARY SHARES | 1M | 99K | – |
AMGEN INC | COM | 4M | 12K | – |
APELLIS PHARMACEUTICALS INC | COM | 2M | 47K | – |
APREA THERAPEUTICS INC | COM NEW | 558K | 137K | – |
ARVINAS INC | COM | 2M | 82K | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 3M | 20K | – |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 3M | 839K | – |
AVADEL PHARMACEUTICALS PLC | COM SHS | 3M | 209K | – |
BIOHAVEN LTD | COM | 3M | 90K | – |
BRIDGEBIO PHARMA INC | COM | 2M | 79K | – |
CABALETTA BIO INC | COM | 2M | 300K | – |
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 2M | 275K | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 4M | 85K | – |
DEXCOM INC | COM | 3M | 26K | – |
DISC MEDICINE INC | COM | 3M | 61K | – |
DR REDDYS LABS LTD | ADR | 3M | 36K | – |
ELEVATION ONCOLOGY INC | COM | 997K | 369K | – |
ELI LILLY & CO | COM | 9M | 10K | – |
ESTABLISHMENT LABS HLDGS INC | COM | 2M | 26K | – |
FULCRUM THERAPEUTICS INC | COM | 2M | 303K | – |
GOSSAMER BIO INC | COM | 1M | 1M | – |
GUARDANT HEALTH INC | COM | 2M | 79K | – |
HILLEVAX INC | COM | 260K | 18K | – |
I MAB | SPONSORED ADS | 453K | 271K | – |
INSMED INC | COM PAR $.01 | 4M | 57K | – |
INTUITIVE SURGICAL INC | COM NEW | 3M | 6K | – |
KURA ONCOLOGY INC | COM | 3M | 132K | – |
MADRIGAL PHARMACEUTICALS INC | COM | 3M | 11K | – |
MASIMO CORP | COM | 2M | 20K | – |
MERUS N V | COM | 7M | 74K | – |
NATERA INC | COM | 2M | 19K | – |
PACIFIC BIOSCIENCES CALIF IN | COM | 103K | 75K | – |
PLIANT THERAPEUTICS INC | COM | 1M | 124K | – |
PMV PHARMACEUTICALS INC | COM | 581K | 358K | – |
PROCAPS GROUP SA | SHS | 877K | 129K | – |
Q32 BIO INC | COM | 787K | 44K | – |
QUANTERIX CORP | COM | 788K | 60K | – |
REZOLUTE INC | COM NEW | 1M | 282K | – |
SAGIMET BIOSCIENCES INC | COM SER A | 173K | 51K | – |
SAREPTA THERAPEUTICS INC | COM | 5M | 33K | – |
SYROS PHARMACEUTICALS INC | COM NEW | 821K | 159K | – |
TG THERAPEUTICS INC | COM | 4M | 252K | – |
THE CIGNA GROUP | COM | 4M | 12K | – |
TRAVERE THERAPEUTICS INC | COM | 4M | 443K | – |
VYNE THERAPEUTICS INC | COM | 696K | 353K | – |
WAVE LIFE SCIENCES LTD | SHS | 4M | 497K | – |
ZAI LAB LTD | ADR | 2M | 87K | – |